Denali Therapeutics Adds $155 Million from Takeda Post author:Sam Post published:March 18, 2018 Post category:BioPharma Denali Therapeutics, located in South San Francisco, California, had a lot of news to share today. Source: BioSpace You Might Also Like Ardelyx Shares Soared After Positive Phase III Results for Tenapanor October 11, 2017 Milestone Scientific CEO Steps Down Months After Taking Job, Interim Leader Named October 5, 2017 Recursion Scores $60 Million to Fund AI-Driven Drug Repurposing, Pipeline Development October 3, 2017
Recursion Scores $60 Million to Fund AI-Driven Drug Repurposing, Pipeline Development October 3, 2017